Loteprednol 0.5%

Loteprednol etabonate ophthalmic suspension 0.5% is indicated for the treatment of steroid responsive inflammatory conditions of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe such as allergic conjunctivitis, acne rosacea, superficial punctate keratitis, herpes zoster keratitis, iritis, cyclitis, selected infective conjunctivitis, when the inherent hazard of steroid use is accepted to obtain an advisable diminution in edema and inflammation.

It may take some time to load the article after you tap to read more.

DailyMed (which is maintained by National Library of Medicine)

https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=f37d74ac-5f9c-40a8-b43b-35148fc66bbe&type=display